Homopolymer and copolymers of 4-nitro-3-methylphenyl methacrylate with glycidyl methacrylate: Synthesis, characterization, monomer reactivity ratios and thermal properties

Add time:07/14/2019    Source:sciencedirect.com

The novel methacrylic monomer, 4-nitro-3-methylphenyl methacrylate (NMPM) was synthesized by reacting 4-nitro-3-methylphenol dissolved in ethyl methyl ketone (EMK) with methacryloyl chloride in the presence of triethylamine as a catalyst. The homopolymer and copolymers of NMPM with glycidyl methacrylate having different compositions were synthesized by free radical polymerization in EMK solution at 70 ± 1 °C using benzoyl peroxide as free radical initiator. The homopolymer and the copolymers were characterized by FT-IR, 1H NMR and 13C NMR spectroscopic techniques. The solubility tests were tested in various polar and non-polar solvents. The molecular weight and polydispersity indices of the copolymers were determined using gel permeation chromatography. The glass transition temperature of the copolymers increases with increase in NMPM content. The thermogravimetric analysis of the polymers performed in air showed that the thermal stability of the copolymer increases with NMPM content. The copolymer composition was determined using 1H NMR spectra. The monomer reactivity ratios were determined by the application of conventional linearization methods such Fineman–Ross (r1 = 1.862, r2 = 0.881), Kelen–Tudos (r1 = 1.712, r2 = 0.893) and extended Kelen–Tudos methods (r1 = 1.889, r2 = 0.884).

We also recommend Trading Suppliers and Manufacturers of N-{4-nitro-2-methylphenyl}-2-{[1-(4-methylphenyl)-1H-tetraazol-5-yl]sulfanyl}acetamide (cas 493014-65-6). Pls Click Website Link as below: cas 493014-65-6 suppliers

Prev:Crystal growth and characterization of an NLO organic crystal: N′-[(Z)-(4-methylphenyl)methylidene]-4-nitrobenzohydrazide
Next:Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor)